9,551
Total Claims
$1.1M
Drug Cost
693
Beneficiaries
$1,637
Cost/Patient
Peer Comparison vs. 4,479 Interventional Cardiology providers
+55%
Cost per patient vs peers
$1,637 vs $1,054 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 8,486 claims · $232K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 359 | $391K |
| Rivaroxaban | 112 | $133K |
| Sacubitril/Valsartan | 79 | $101K |
| Ticagrelor | 125 | $87K |
| Evolocumab | 82 | $84K |
| Rosuvastatin Calcium | 906 | $29K |
| Vericiguat | 14 | $28K |
| Metoprolol Succinate | 773 | $21K |
| Ranolazine | 138 | $19K |
| Nitroglycerin | 271 | $13K |
| Clopidogrel Bisulfate | 571 | $11K |
| Potassium Chloride | 360 | $9,259 |
| Ezetimibe | 238 | $9,048 |
| Fluticasone Propion/Salmeterol | 15 | $7,559 |
| Varenicline Tartrate | 13 | $6,406 |
Prescribing Profile
74
Unique Drugs
$625K
Patient Profile
74
Avg Age
58%
Female
1.78
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About